A Pilot Study on the Views and Experiences of Healthcare Providers about Deprescribing Preventive Medications in Patients with Polypharmacy

Author:

Oktora Monika Pury1,Yuniar Cindra Tri2,Alfian Sofa Dewi1,Hak Eelko3,Abdulah Rizky1

Affiliation:

1. Universitas Padjadjaran (UNPAD)

2. Institut Teknologi Bandung (ITB)

3. University of Groningen

Abstract

Abstract

Background Deprescribing is a process of tapering or stopping medications to achieve improved health outcomes. The process is widely recommended to reduce the burden of polypharmacy in older or frail patients. Healthcare providers’ (HCPs) role has been reported to be important when deprescribing in clinical practice. Despite the potential, little is known about the views and experiences of HCPs about deprescribing in Indonesia. Therefore, this study aims to present the preliminary results of the views and experiences of HCPs in Indonesia about deprescribing medications in patients with polypharmacy. Methods The study was carried out using semi-structured interviews with three HCPs, comprising a general practitioner (GP), internist, and pharmacist, who were selected as informants. Interviews were recorded and transcribed verbatim, and directed content analysis was performed to extract the data. Results Themes about HCPs’ knowledge, skills, experience, and interaction between HCPs, patients, and patient families were found. Although the HCPs understood the importance of deprescribing, some challenges in implementing the process were admitted. These comprised a lack of specific guidelines, barriers to communication skills, building trust from the patients, and insufficient time and resources to support deprescribing decisions. Therefore, closer collaboration between HCPs and good interaction with patients and their families may be favorable when conducting deprescribing. Conclusion This first exploration study showed that there were most likely knowledge gaps in deprescribing practices in Indonesia, particularly regarding preventive medications in patients with polypharmacy. Consequently, studies involving more HCPs may help determine their roles in deprescribing and the barriers and enablers to implementation.

Publisher

Springer Science and Business Media LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3